MicroRNA-547-5p-mediated interleukin-33/suppressor of tumorigenicity 2 signaling underlies the genesis and maintenance of neuropathic pain and is targeted by the therapy with bone marrow stromal cells

Interleukin-33 (IL-33)/suppressor of tumorigenicity 2 (ST2) signaling is known to promote inflammation and the genesis and maintenance of neuropathic pain. However, it remained mostly unknown how IL-33/ST2 signaling can be enhanced by neuropathic stimulations. Here, we report that the chronic constr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ju, Zhuang, Ting, Ma, Peng, Shan, Lidong, Sun, Xiao-Dong, Gong, Shan, Tao, Jin, Yu, Xian-Min, Jiang, Xinghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309409/
https://www.ncbi.nlm.nih.gov/pubmed/32513089
http://dx.doi.org/10.1177/1744806920931737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309409/
https://www.ncbi.nlm.nih.gov/pubmed/32513089
http://dx.doi.org/10.1177/1744806920931737

Ejemplares similares